Innate Pharma
IPHA
#8408
Rank
NZ$0.28 B
Marketcap
$3.27
Share price
-4.19%
Change (1 day)
-21.16%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -NZ$14.96 Million

According to Innate Pharma 's latest financial reports the company's current earnings are NZ$57.37 Million. In 2023 the company made an earning of -NZ$14.96 Million, an increase over its 2022 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-NZ$14.96 Million-86.54%
2022-NZ$0.12 Billion20.74%
2021-NZ$92.03 Million4951.09%
2020-NZ$1.83 Million-111.57%
2019NZ$15.74 M183.46%
2018NZ$5.55 M-105.4%
2017-NZ$0.11 Billion-523.25%
2016NZ$24.32 M-285.64%
2015-NZ$13.11 Million-69.31%
2014-NZ$42.7 Million498.29%
2013-NZ$7.14 Million-5.62%
2012-NZ$7.57 Million-53.32%
2011-NZ$16.2 Million-50.1%
2010-NZ$32.46 Million-13.3%
2009-NZ$37.44 Million26.36%
2008-NZ$29.63 Million27.35%
2007-NZ$23.27 Million63.33%
2006-NZ$14.25 Million9.81%
2005-NZ$12.98 Million